The good news: As the weather is turning warmer, flu season is officially headed off a cliff. The bad news: The efficacy of ...

The Centers for Disease Control and Prevention released a report March 12 on the effectiveness of the flu vaccine for the ...

As the U.S. flu season winds down, health officials say the flu vaccine didn’t work very well. It had one of its worst effectiveness rates in more than a decade.

Incentives to bring vaccines to market are shrinking. Drugmakers are scaling back research investments and cutting jobs.

Flu activity in the United States is finally slowing down, but health experts say this year’s flu vaccine didn't offer as ...

With the reversal from the FDA, Moderna said it is aiming to make the vaccine available for the 2026-27 flu season.

In early 2026, Moderna reported encouraging long-term data for its personalized cancer vaccine mRNA-4157 (V940) in high-risk melanoma, while the FDA granted expedited review and an August 5, 2026 ...

The U.S. Food and Drug Administration (FDA) recently informed Moderna that it would not review the company’s application for approval of its new flu vaccine, which is its first using mRNA technology ...

Many kids are scared of getting needles, and this can stop them getting vaccinations that protect that against the flu. Less than 1 in 4 Australian children were vaccinated against influenza in 2025.

Some public health officials say ICE activity and federal vaccine actions have caused confusion and fear, leading to fewer shots.